For example, Liberati et al. (18) found that although MET mutations and amplifications are uncommon in ESCC (affecting only 5–6% of cases), 84% of cases exhibit at least a twofold increase in c-MET protein expression. This evidence concerns the gene MET and esophageal squamous cell carcinoma.